Chembio Diagnostics Inc (NASDAQ:CEMI)

3.56
Data as of 3:59pm ET
 +0.044 / +1.25%
Today’s Change
2.83
Today|||52-Week Range
4.13
+5.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$33.8M

Company Description

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. Its main products presently commercially available are four rapid tests for the detection of HIV antibodies. The company sells its products under its STAT PAK, SURE CHECK or DPP trademarks. The company's business roots back to 1985. Chembio Diagnostics was founded on May 5, 2004 and is headquartered in Medford, NY.

Contact Information

Chembio Diagnostics, Inc.
3661 Horseblock Road
Medford New York 11763
P:(631) 924-1135
Investor Relations:
16319241135125

Employees

Shareholders

Mutual fund holders2.43%
Other institutional15.15%
Individual stakeholders11.99%

Top Executives

John J. SperzelPresident, Chief Executive Officer & Director
Sharon KlugewiczChief Operating Officer
Richard J. LarkinChief Financial Officer
Javan EsfandiariExecutive Vice President-Research & Development
Richard BruceVice President-Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.